| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Letter to the Editor |
| Article Title |
Promise and challenges of traditional Chinese medicine, specifically Calculus bovis, in liver cancer treatment
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Ao-Xi Xu, Zhi-Feng Zhao, Li Zhu, Yi-Heng Zhang, Yan Li, Yu-Fan Wei, Bo-Ya Zhang, Bin Jiang, Tian-Ze Gao, Meng-Si Li and Jia-Yu Liu |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Jia-Yu Liu, MD, PhD, Attending Doctor, Department of Neurosurgery, First Medical Centre of Chinese People's Liberation Army General Hospital, No. 28 Fuxing Road, Haidian District, Beijing 100853, China. liujiayu@pku.edu.cn |
| Key Words |
Traditional Chinese medicine; Liver cancer; Calculus Bovis; Treatment; Promise; Challenges |
| Core Tip |
Huang et al discovered that CB inhibits liver cancer growth by mediating the suppression of M2-TAM polarization through the Wnt/β-catenin pathway. This article highlights the current research, potential, and challenges of using traditional Chinese medicine, exemplified by Calculus Bovis, in liver cancer treatment, and points to future research directions. |
| Publish Date |
2024-10-16 06:29 |
| Citation |
<p>Xu AX, Zhao ZF, Zhu L, Zhang YH, Li Y, Wei YF, Zhang BY, Jiang B, Gao TZ, Li MS, Liu JY. Promise and challenges of traditional Chinese medicine, specifically Calculus bovis, in liver cancer treatment. <i>World J Gastroenterol</i> 2024; 39(40): 4380-4385</p> |
| URL |
https://www.wjgnet.com/1007-9327/full/v30/i40/4380.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v30.i40.4380 |
